Landmark Anti-dyslipidemic Trials Update - How Low Can You Go? - Market Research Reports

Printer Friendly

Printed from http://www.researchandmarkets.com/reports/220048

Landmark Anti-dyslipidemic Trials Update - How Low Can You Go?

Description:

Introduction
The Heart Protection Study showed that patients with normal LDL cholesterol, as defined by the NCEP guidelines, experienced equal benefit from LDL cholesterol reduction as those with high LDL cholesterol. These results have been confirmed by the REVERSAL, PROVE-IT and ALLIANCE trials, which have shown the benefit of intensive statin therapy to reduce LDL cholesterol below current targets.

Scope
Evaluation of recent data supporting the use of intensive statin therapy and lower LDL cholesterol target levels
Discussion of the current barriers to the therapeutic strategies proposed by recent trials
Highlights
Recent clinical trial data suggest that using intensive cholesterol-lowering therapy to reduce LDL cholesterol levels below current target levels is beneficial. On the basis of these results, current cholesterol targets may need to be revised as they may lead to patients being undertreated.

Reasons to Purchase
Understand the rationale behind the proposal to reduce LDL cholesterol targets
Identify the barriers to intensive cholesterol-lowering therapy using high dose statins

Contents:

TABLE OF CONTENTS
EXECUTIVE SUMMARY 4
Introduction 4
Scope and coverage of the Brief 4
Key findings about the topic 5
CURRENT TREATMENT GUIDELINES 8
HOW LOW SHOULD YOU GO? 12
CLINICAL TRIALS 15
DISCUSSION 28
APPENDIX 47
Bibliography 47

Ordering:

Order Online - visit http://www.researchandmarkets.com/reports/220048

Order by Fax - using the order form below

Order By Post - print the order form below and send to

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.

Page 1 of 2
Printed 27/11/2009 20:00:13

Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to
646-607-1907 (from USA) or +353 1 6849977 (from Rest of World). If you have any questions please email help@researchandmarkets.net

Order information
Please verify that the product information is correct and select the format you require.


Product Name:
Landmark Anti-dyslipidemic Trials Update - How Low Can You Go?
Web Address:
http://www.researchandmarkets.com/reports/220048
Office Code:
OC8HJNPOUMUXU

Report formats
Please enter the quantity of the report format you require.

	Format	Quantity	Price
	Electronic		€1,276.00

Contact information
Please enter all the information below in BLOCK CAPITALS.


	First Name:	Last Name:
	Email Address:
	Job Title:
	Organisation:
	Address:
	City:
	Postal/Zip Code:
	Country:
	Phone Number:
	Fax Number:

Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)

Page 2 of 2
Printed 27/11/2009 20:00:13

Payment information

Please indicate the payment method you would like to use by selecting the appropriate box.

Pay by Credit Card:

	American Express
	Diners Club
	Master Card
	Visa


Cardholder's Name:

Cardholder's Signature:

Expiry Date:	/

Card Number:

CVV Security Code:

Issue Date:	/ (Diners Club only)

Pay by Check:

Please post the check, accompanied by this form, to:

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.

Pay by Wire Transfer:

Please transfer funds to:


Account number:	83313083
Sort code:	98-53-30
Swift code:	ULSBIE2D
IBAN number:	IE78ULSB98533083313083
Bank Address:	Ulster Bank, 27-35 Main St, Blackrock, Co. Dublin, Ireland.

If you have a Marketing Code please enter it below:
	Marketing Code:

Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp

Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)